(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(0.12%) $82.73
(0.94%) $2.05
(-0.43%) $2 347.50
(-0.80%) $27.44
(-0.16%) $960.00
(-0.21%) $0.933
(-0.33%) $10.99
(-0.54%) $0.796
(1.55%) $93.30
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 8.94%
@ $49.09
Utstedt: 14 feb 2024 @ 15:30
Avkastning: 14.42%
Forrige signal: feb 9 - 21:40
Forrige signal:
Avkastning: -2.06 %
Live Chart Being Loaded With Signals
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support...
Stats | |
---|---|
Dagens volum | 705 592 |
Gjennomsnittsvolum | 671 158 |
Markedsverdi | 3.03B |
EPS | $0 ( 2024-02-21 ) |
Neste inntjeningsdato | ( $0.450 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 175.53 |
ATR14 | $0.0660 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-30 | Bolton Stephanie | Buy | 7 744 | Ordinary Shares |
2024-03-30 | Bolton Stephanie | Buy | 10 746 | Stock Appreciation Rights |
2024-03-30 | Bolton Stephanie | Sell | 3 643 | Ordinary Shares |
2024-03-30 | Bolton Stephanie | Buy | 4 915 | Restricted Stock Units |
2024-03-30 | Bolton Stephanie | Buy | 4 915 | Performance Stock Units |
INSIDER POWER |
---|
50.90 |
Last 100 transactions |
Buy: 371 593 | Sell: 126 373 |
Volum Korrelasjon
LivaNova PLC Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
IMPL | 0.932 |
AFYA | 0.931 |
JFU | 0.928 |
INVA | 0.925 |
EAR | 0.923 |
AVIR | 0.923 |
TUEM | 0.922 |
DTSS | 0.92 |
AZTA | 0.91 |
IMV | 0.91 |
10 Mest negative korrelasjoner | |
---|---|
SERA | -0.945 |
NEO | -0.938 |
XLRN | -0.93 |
TA | -0.93 |
MLTX | -0.922 |
NTRA | -0.92 |
ZGNX | -0.91 |
XPON | -0.909 |
CPTA | -0.908 |
PAE | -0.908 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
LivaNova PLC Korrelasjon - Valuta/Råvare
LivaNova PLC Økonomi
Annual | 2023 |
Omsetning: | $1.15B |
Bruttogevinst: | $785.45M (68.09 %) |
EPS: | $0.330 |
FY | 2023 |
Omsetning: | $1.15B |
Bruttogevinst: | $785.45M (68.09 %) |
EPS: | $0.330 |
FY | 2022 |
Omsetning: | $1.02B |
Bruttogevinst: | $707.20M (69.21 %) |
EPS: | $-1.610 |
FY | 2021 |
Omsetning: | $1.04B |
Bruttogevinst: | $705.99M (68.19 %) |
EPS: | $-2.68 |
Financial Reports:
No articles found.
LivaNova PLC
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.